Live Breaking News & Updates on Leerink partnrs

Stay informed with the latest breaking news from Leerink partnrs on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Leerink partnrs and stay connected to the pulse of your community

Laboratory Co. of America (NYSE:LH) Releases FY24 Earnings Guidance

Laboratory Co. of America (NYSE:LH – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $14.45-15.35 for the period, compared to the consensus estimate of $14.84. Laboratory Co. of America also updated its FY 2024 guidance to 14.450-15.350 EPS. Analysts Set New Price Targets Several […]

United-states , America , Robertw-baird , Vaart-sandrad-van , Leerink-partnrs , Laboratory-corporation-of-america-holdings , Biopharma-laboratory-services , America-company-profile , News-ratings-for-laboratory-co , Laboratory-co , Securities-exchange-commission , Get-free-report

Jackson Hole Capital Partners LLC Invests $211,000 in Laboratory Co. of America Holdings (NYSE:LH)

Jackson Hole Capital Partners LLC bought a new stake in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 930 shares of the medical research company’s stock, valued at approximately $211,000. […]

Wellington , New-zealand-general- , New-zealand , United-states , America , Marks-schroeder , Amyb-summy , Leerink-partnrs , Laboratory-co , Wellington-management-group , America-holdings , Exchange-commission

Kyverna Therapeutics (NASDAQ:KYTX) Hits New 12-Month Low at $17.70

Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) shares hit a new 52-week low on Wednesday . The stock traded as low as $17.70 and last traded at $17.75, with a volume of 81775 shares. The stock had previously closed at $19.19. Wall Street Analysts Forecast Growth Several brokerages recently weighed in on KYTX. Morgan […]

Leerink-partnrs , Nasdaq , Kyverna-therapeutics-company-profile , Morgan-stanley , Wells-fargo-company , Northpond-ventures-iii-gp-llc , Jpmorgan-chase-co , Kyverna-therapeutics-inc , Kyverna-therapeutics , Get-free-report , Wells-fargo , Therapeutics-trading-down

6,726 Shares in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Acquired by Callan Capital LLC

Callan Capital LLC acquired a new position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,726 shares of the company’s stock, valued at approximately $239,000. Other hedge funds have also […]

United-states , Yujiros-hata , Briseno-andres-ruiz , Leerink-partnrs , Werner-helicase , Nasdaq , Jpmorgan-chase-co , Eventide-asset-management , Barclays-plc , Biosciences-inc , Goldman-sachs-group , Walleye-capital

Cartesian Therapeutics' (RNAC) Outperform Rating Reiterated at Leerink Partnrs

Leerink Partnrs reiterated their outperform rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a research note released on Tuesday, Zacks.com reports. Leerink Partnrs also issued estimates for Cartesian Therapeutics’ Q1 2024 earnings at ($1.34) EPS, Q2 2024 earnings at ($1.38) EPS, Q3 2024 earnings at ($1.27) EPS, Q4 2024 earnings at ($1.09) […]

Hall-laurie , Timothya-springer , Leerink-partnrs , Nasdaq , Exchange-commission , Needham-company , Securities-exchange-commission , Cartesian-therapeutics-company-profile , Cartesian-therapeutics-inc , Cartesian-therapeutics , Free-report , Get-free-report

Kyverna Therapeutics (NASDAQ:KYTX) Stock Price Down 6.6%

Kyverna Therapeutics (NASDAQ:KYTX) Stock Price Down 6.6%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Leerink-partnrs , Kyverna-therapeutics-inc , Wells-fargo-company , Northpond-ventures-iii-gp-llc , Nasdaq , Kyverna-therapeutics-company-profile , Securities-exchange-commission , Jpmorgan-chase-co , Morgan-stanley , Kyverna-therapeutics , Get-free-report , Therapeutics-stock-down

Cardinal Health (NYSE:CAH) Rating Lowered to Buy at StockNews.com

Cardinal Health (NYSE:CAH – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Wednesday. Several other research analysts also recently weighed in on CAH. Leerink Partnrs reiterated an “outperform” rating on shares of Cardinal Health […]

Canada , United-states , Leerink-partnrs , Capital-management , Analyst-recommendations-for-cardinal-health , Pacer-advisors-inc , News-ratings-for-cardinal-health-daily , Cardinal-health , Ameriprise-financial-inc , Northern-trust-corp , Barclays , Cardinal-health-inc

McClarren Financial Advisors Inc. Buys New Position in McKesson Co. (NYSE:MCK)

McClarren Financial Advisors Inc. purchased a new position in McKesson Co. (NYSE:MCK – Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 371 shares of the company’s stock, valued at approximately $172,000. Other large investors also recently made changes to their positions in […]

Washington , United-states , Leerink-partnrs , Leannb-smith , Brians-tyler , Mcclarren-financial-advisors-inc , Securities-exchange-commission , Wealth-management , Mckesson-corporation , Avior-wealth-management , Prescription-technology-solutions-rx , Morgan-stanley

HC Wainwright Weighs in on Cartesian Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:RNAC)

HC Wainwright Weighs in on Cartesian Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:RNAC)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hall-laurie , Leerink-partnrs , Timothya-springer , Cartesian-therapeutics-inc , Exchange-commission , Needham-company , Nasdaq , Cartesian-therapeutics-company-profile , Cartesian-therapeutics , Free-report , Cartesian-therapeutic , Get-free-report

NeuroPace, Inc. (NASDAQ:NPCE) Major Shareholder Orbimed Advisors Llc Sells 24,609 Shares

NeuroPace, Inc. (NASDAQ:NPCE – Get Free Report) major shareholder Orbimed Advisors Llc sold 24,609 shares of the firm’s stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $14.05, for a total value of $345,756.45. Following the completion of the transaction, the insider now owns 3,459,113 shares of […]

United-states , Leerink-partnrs , Wells-fargo-company , Nasdaq , Morgan-stanley , Barclays-plc , Orbimed-advisors-llc , Cantor-fitzgerald , Citigroup-inc , Kent-lake-capital , Neuropace-inc , Get-free-report